Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Medicare Part B Premium Hike To Accommodate Alzheimer’s Drug Costs Is Premature – Sen. Wyden
Dec 15 2021
•
By
Cathy Kelly
Wyden Agrees Aduhelm's Cost Too High But Doesn't Want Higher Premiums • Source: Alamy
Learn what's happening at the US FDA. On the go.
Derrick Gingery and the team bring you a weekly "Drug Fix".
More from Market Access
More from Pink Sheet